- Narrative Type
| - Narrative Text
|
| Additional Text | As announced by Singapore Medical Group Limited (the "Company") on 29 November 2022, the percentage of the total number of issued shares (excluding treasury shares) of the Company held by the public has on 28 November 2022 fallen below 10%. |
| Additional Text | As the offer has closed at 5.30 p.m. (Singapore time) on 19 December 2022, the Company has accordingly requested the Singapore Exchange Securities Trading Limited to suspend the trading of the Company's shares with effect from 9.00 a.m. (Singapore time) on 20 December 2022. |
| Additional Text | This announcement has been prepared by Singapore Medical Group Limited ("Company") and its contents have been reviewed by the Company's sponsor, UOB Kay Hian Private Limited ("Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. |
| Additional Text | This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement. |
| Additional Text | The contact person for the Sponsor is Mr Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881. |